Rockefeller Capital Management L.P.

Position in CRDF — Cardiff Oncology, Inc.

CIK 1739439 NEW YORK, NY

Position in CRDF

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$26,000

-$65,530 QoQ

Shares Held

20,000

-64.6% QoQ

Ownership

0.026%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 104 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $308,249,937 across 242 Biotechnology names. CRDF ranks #119 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	149,476	$74,249,211
2	JAZZ	Jazz Pharmaceuticals plc	167,409	$40,340,545
3	ACAD	Acadia Pharmaceuticals Inc	1,015,420	$25,690,124
4	BMRN	Biomarin Pharmaceutical Inc	433,376	$24,797,774
5	PTCT	Ptc Therapeutics, Inc.	302,393	$24,666,195
6	MDGL	Madrigal Pharmaceuticals, Inc.	29,015	$15,579,603
7	REGN	Regeneron Pharmaceuticals, Inc.	21,563	$13,445,391
8	CORT	Corcept Therapeutics Inc	123,388	$10,728,585

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,000	20,000	-64.6%	Shares	Defined	2026-08-13
2026-03-31	$91,530	56,500	0.0%	Shares	Defined	2026-05-14
2025-12-31	$158,765	56,500	-9.6%	Shares	Defined	2026-03-17
2025-09-30	$128,750	62,500	+38243.6%	Shares	Defined	2025-11-14
2022-09-30	$251	163	0.0%	Shares	Defined	2022-11-02
2022-06-30	$358	163	+2228.6%	Shares	Defined	2022-08-12
2022-03-31	$17	7	+16.7%	Shares	Defined	2022-05-13
2021-12-31	$36	6	-99.3%	Shares	Defined	2022-02-14
2021-06-30	$5,865	882	-28.6%	Shares	Defined	2021-08-10
2021-03-31	$11,436	1,235	+609.8%	Shares	Defined	2021-05-11
2020-12-31	$3,130	174	-97.5%	Shares	Defined	2021-02-12
2020-09-30	$100,096	7,054	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.